Scientists use AI to develop bird flu vaccine that outperforms current stockpiled shot
A University of Cambridge team has had a third success with its AI-guided technique for designing vaccines against highly infectious viruses that threaten animal and human health. Its new broad-spectrum bird flu vaccine gave complete protection against globally circulating, diverse variants of the disease in animal trials.
A University of Cambridge research team has successfully developed a new AI-guided vaccine for bird flu that provides complete protection against diverse virus variants in animal trials. This innovative vaccine outperforms current stockpiled bird flu vaccines, which only offer around 50% protection when exposed to multiple variants.
The new broad-spectrum vaccine, created by DIOSynVax Ltd., is designed to anticipate viral evolution rather than react to it. Unlike existing vaccines that focus on a single strain, this universal vaccine targets thousands of potential variants, offering long-term protection. The study, published in Cell Reports Medicine, demonstrates the potential of AI-guided vaccine design in creating broad protective immunity ahead of evolving biological threats, aligning with global biosecurity priorities.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
